Fred Cohen

Current

• Sr. Director, Portfolio Development at Eurand
• President at Pharma Growth Strategies

Education

• National Institutes of Health
• Wake Forest University School of Medicine
• Pennsylvania State University College of Medicine

1 more...

Recommended

10 people have recommended Fred

Connections

500+ connections

Industry

Pharmaceuticals

Fred Cohen’s Summary

Entrepreneurial physician-scientist with hands-on experience in all facets of the pharmaceutical industry, from drug discovery through pricing and reimbursement, with particular interests in R&D productivity and innovation facilitation. Currently working to build a robust portfolio of development-stage products at Eurand Pharmaceuticals, a specialty pharma that has been known primarily for its formulation capabilities.

Since 2004, I am president of Pharma Growth Strategies, LLC (www.pharmagrowth.com), a specialty management consultant to the life science sector, offering strategic and tactical R&D and marketing services.

I formerly actively wrote Pharma's Cutting Edge, a blog devoted to the pharma/biotech sector. Archives available at www.pharmaweblog.com.

Work/Education:
Fast Track Systems, Inc. (Medidata Sol WW), Vice President
Pharma Growth Strategies LLC, President
Crownstone, President
Johnson & Johnson Pharma Rsrch & Devpt, Sr. Director, Drug Development
Eli Lilly & Company, Clinical Research Physician
National Institutes of Health, Research Fellow (Endocrine/metabolism)
Wake Forest University Medical Center, Resident (IM)
Penn State University College of Medicine, M.D.
Franklin & Marshall College, AB

Selected recent publications:
Optimizing Clinical Protocol Development to Enhance Research Productivity - Next Gen Pharma (NGP)
Procedure-related Benchmarks to Inform and Streamline Study Design - NGP
Build or Buy Critical eClinical Applications - NGP
The Extensible Clinical Protocol: Setting Up Trials for Successful Execution - NGP
Entry Order as a Consideration for Innovation Strategies - Nature Rev Drug Disc (NRDD)
Macro Trends in Pharmaceutical Innovation - NRDD
Trends in Antihyperglycemic Prescribing - Diabetes Care

Fred Cohen’s Specialties:

Pharmaceutical, Drug, R&D, Biotechnology, Clinical Research, Research Technology, Development, Discovery, Preclinical, Clinical, Operations, Productivity, Innovation, Strategic Development, Licensing, Business Development, Strategic Marketing, eClinical, Knowledge Management, Operations Research, Market Access, Outcomes Research, EDC, Data Management, Diabetes, Endocrinology, Metabolism, Osteoporosis, Breast Cancer, Oncology, Cardiometabolic, Women's Health